Home › Collections › HMP2 / IBDMDB longitudinal IBD multi-omics cohort
HMP2 / IBDMDB longitudinal IBD multi-omics cohort
Benchmark and reference cohorts · collection id hmp2-ibdmdb
The Integrative HMP inflammatory bowel disease cohort (IBDMDB): 132 subjects with Crohn's disease, ulcerative colitis or no IBD, followed for one year with stool metagenomes, metatranscriptomes and biopsies at five US centres.
Open in the sample explorer (2,341 samples)
2
studies with member samples
2,341
member samples in this release
Membership rule
| Studies | PRJNA398089, PRJNA389280 |
Composition
Age category
| adult | 883 |
| adolescent | 719 |
| child | 358 |
| unknown | 306 |
| elderly | 75 |
Country
| US | 2,341 |
Health condition
| ibd_or_gi_disease IBD or GI disease (infant) | 1,496 |
| healthy_control Healthy / control | 600 |
| crohns_disease Crohn's disease | 144 |
| ulcerative_colitis Ulcerative colitis | 78 |
| ibd_unspecified IBD (unspecified) | 23 |
Member studies (2)
| Study | Title | Member samples | First public |
|---|---|---|---|
| PRJNA398089 | Longitudinal Multi’omics of the Human Microbiome in Inflammatory Bowel Disease | 2,041 | 2017 |
| PRJNA389280 | Human gut metagenome and metatranscriptome in the inflammatory bowel disease (iHMP/HMP2) | 300 | 2017 |